Dianthus Therapeutics, Inc. /DE/ Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2023-11-09: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2023-08-03: Form 10-Q; Item Security registered under Section 12(b); As filed Preferred Stock · NASDAQ.
- 2023-08-03: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock · MGTA · NASDAQ.
- 2023-08-03: Form 10-Q; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|
| 2023-11-09 | 10-Q | Emerging growth company | Yes |
|---|
| 2023-08-03 | 10-Q | Security registered under Section 12(b) | Preferred Stock · NASDAQ |
|---|
| 2023-08-03 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · NASDAQ |
|---|
| 2023-08-03 | 10-Q | Emerging growth company | Yes |
|---|
| 2023-05-15 | 10-Q | Security registered under Section 12(b) | Preferred Stock · The Nasdaq Global Market |
|---|
| 2023-05-15 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2023-05-15 | 10-Q | Emerging growth company | Yes |
|---|
| 2023-05-01 | 10-K/A | Security registered under Section 12(b) | Preferred Stock Purchase Rights · NASDAQ |
|---|
| 2023-05-01 | 10-K/A | Stock registered under Section 12(b) | Common Stock, $0.001 Par Value · MGTA · NASDAQ |
|---|
| 2023-05-01 | 10-K/A | Emerging growth company | Yes |
|---|
| 2023-03-23 | 10-K | Public float as of 2022-06-30 | $56.30M |
|---|
| 2023-03-23 | 10-K | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2023-03-23 | 10-K | Emerging growth company | Yes |
|---|
| 2022-11-03 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2022-11-03 | 10-Q | Emerging growth company | Yes |
|---|
| 2022-08-04 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2022-08-04 | 10-Q | Emerging growth company | Yes |
|---|
| 2022-05-16 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2022-05-16 | 10-Q | Emerging growth company | Yes |
|---|
| 2022-03-08 | 10-K | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2022-03-08 | 10-K | Emerging growth company | Yes |
|---|
| 2021-11-04 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2021-11-04 | 10-Q | Emerging growth company | Yes |
|---|
| 2021-08-05 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2021-08-05 | 10-Q | Emerging growth company | Yes |
|---|
| 2021-05-06 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2021-05-06 | 10-Q | Emerging growth company | Yes |
|---|
| 2021-03-03 | 10-K | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2021-03-03 | 10-K | Emerging growth company | Yes |
|---|
| 2020-11-05 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2020-11-05 | 10-Q | Emerging growth company | Yes |
|---|
| 2020-08-06 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · The Nasdaq Global Market |
|---|
| 2020-08-06 | 10-Q | Emerging growth company | Yes |
|---|
| 2020-05-07 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · NASDAQ |
|---|
| 2020-05-07 | 10-Q | Emerging growth company | Yes |
|---|
| 2020-03-03 | 10-K | Stock registered under Section 12(b) | Common Stock · MGTA · NASDAQ |
|---|
| 2020-03-03 | 10-K | Emerging growth company | Yes |
|---|
| 2019-11-13 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · NASDAQ |
|---|
| 2019-11-13 | 10-Q | Emerging growth company | Yes |
|---|
| 2019-08-08 | 10-Q | Stock registered under Section 12(b) | Common Stock · MGTA · NASDAQ |
|---|
| 2019-08-08 | 10-Q | Emerging growth company | Yes |
|---|
| 2019-05-09 | 10-Q | Emerging growth company | Yes |
|---|
| 2019-03-19 | 10-K | Emerging growth company | Yes |
|---|
| 2018-11-08 | 10-Q | Smaller reporting company | No |
|---|
| 2018-11-08 | 10-Q | Emerging growth company | Yes |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|